Inappropriate left ventricular mass and poor outcomes in patients with angina pectoris and normal ejection fraction

Coronary Artery Disease

Volumn 26, Issue 2, 2015, Pages 163-169

  Huang, Bao Tao ^a   Peng, Yong ^a   Liu, Wei ^a   Zhang, Chen ^a   Huang, Fang Yang ^a   Wang, Peng Ju ^a   Zuo, Zhi Liang ^a   Liao, Yan Biao ^a   Chai, Hua ^a   Li, Qiao ^a   Zhao, Zhen Gang ^a   Luo, Xiao Lin ^a   Ren, Xin ^a   Huang, Kai Sen ^a   Meng, Qing Tao ^a   Chen, Chi ^a   Huang, De Jia ^a   Chen, Mao ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

coronary artery disease; echocardiography; left ventricular hypertrophy; left ventricular remolding; outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HEMODYNAMICS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; ANGIOCARDIOGRAPHY; BLOOD PRESSURE; ELECTROCARDIOGRAPHY; HEART VENTRICLE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY;

AGED; ANGINA PECTORIS; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME;

EID: 84923069271     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0000000000000190     Document Type: Article

References (33)

1. Bauters C, Deneve M, Tricot O, Meurice T, Lamblin N. CORONOR Investigators. Prognosis of patients with stable coronary artery disease (from the CORONOR study). Am J Cardiol 2014; 113:1142-1145.
2. Holmvang L, Jurlander B, Leibrandt P, Ellis A, Wagner G. Excellent prognosis in patients with unstable angina pectoris classified as 'low risk' at admission despite presence of severe coronary artery disease. Am J Cardiol 2001; 88: A6-A7, 65-67.
3. Mureddu GF, Pasanisi F, Palmieri V, Celentano A, Contaldo F, de Simone G. Appropriate or inappropriate left ventricular mass in the presence or absence of prognostically adverse left ventricular hypertrophy. J Hypertens 2001; 19:1113-1119.
4. De Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension 2001; 38:13-18.
5. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18:1440-1463.
6. Woodiwiss AJ, Libhaber CD, Libhaber E, Sareli P, Norton GR. Relationship between on-treatment decreases in inappropriate versus absolute or indexed left ventricular mass and increases in ejection fraction in hypertension. Hypertension 2012; 60:810-817.
7. Libhaber CD, Norton GR, Maseko MJ, Majane OH, Millen AM, Maunganidze F, et al. Relationship between inappropriate left ventricular hypertrophy and ejection fraction independent of absolute or indexed mass in a community sample of black African ancestry. J Hypertens 2013; 31:169-176.
8. De Simone G, Devereux RB, Kimball TR, Mureddu GF, Roman MJ, Contaldo F, Daniels SR. Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 1998; 31:1077-1082.
9. De Simone G, Kitzman DW, Palmieri V, Liu JE, Oberman A, Hopkins PN, et al. Association of inappropriate left ventricular mass with systolic and diastolic dysfunction: the HyperGEN study. Am J Hypertens 2004; 17:828-833.
10. Chinali M, De Marco M, D'Addeo G, Benincasa M, Romano C, Galderisi M, de Simone G. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities. J Hypertens 2007; 25:1073-1078.
11. Ratto E, Leoncini G, Viazzi F, Bezante GP, Falqui V, Parodi A, et al. Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension. J Hypertens 2008; 26:345-350.
12. Muiesan ML, de Simone G, Ganau A, Longhini C, Verdecchia P, Mancia G, Agabiti-Rosei E.Working Group on Heart and Hypertension of Italian Society of Hypertension. Inappropriate left ventricular mass: reliability and limitations of echocardiographic measurement for risk stratification and follow-up in single patients. J Hypertens 2006; 24:2293-2298.
13. De Simone G, Verdecchia P, Pede S, Gorini M, Maggioni AP. Prognosis of inappropriate left ventricular mass in hypertension: the MAVI Study. Hypertension 2002; 40:470-476.
14. Cioffi G, Rossi A, Zoppini G, Targher G, de Simone G, Devereux RB, et al. Inappropriate left ventricular mass independently predicts cardiovascular mortality in patients with type 2 diabetes. Int J Cardiol 2013; 168:4953-4956.
15. Chen SC, Chang JM, Liu WC, Chen YY, Chen LI, Huang JC, et al. The ratio of observed to predicted left ventricular mass is independently associated with increased cardiovascular events in patients with chronic kidney disease. Hypertens Res 2012; 35:832-838.
16. Holloway CJ, Montgomery HE, Murray AJ, Cochlin LE, Codreanu I, Hopwood N, et al. Caudwell Xtreme Everest Research Group. Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest Base Camp. FASEB J 2011; 25:792-796.
17. Gregori M, Tocci G, Befani A, Ciavarella GM, Ferrucci A, Paneni F. Synergic effect of high renin and aldosterone levels on inappropriate left ventricular mass and systolic function: a tissue Doppler study. Int J Cardiol 2013; 168:4934-4936.
18. Celentano A, Pietropaolo I, Palmieri V, Di Palma Esposito N, Crivaro M, Cirillo F, et al. Inappropriate left ventricular mass and angiotensin converting enzyme gene polymorphism. J Hum Hypertens 2001; 15:811-813.
19. Madaj PM, Pagali SR, Hamirani YS, Raina S, Nair S, Zeb I, et al. Coronary artery calcium and plaque association with left ventricular mass, assessed by multi-row detector computed tomography. Coron Artery Dis 2010; 21:428-434.
20. Stanford W, Thompson BH, Weiss RM. Coronary artery calcification: clinical significance and current methods of detection. Am J Roentgenol 1993; 161:1139-1146.
21. Bangalore S, Vlachos HA, Selzer F, Wilensky RL, Kip KE, Williams DO, Faxon DP. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc Interv 2011; 77 :22-28.
22. Kozàkovà M, de Simone G, Morizzo C, Palombo C. Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass. Hypertension 2003; 41:224-229.
23. Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009; 52:153-167.
24. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
25. Badheka AO, Shah N, Grover PM, Patel NJ, Chothani A, Mehta K, et al. Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategy. Am J Cardiol 2014; 113:1159-1165.
26. Turakhia MP, Schiller NB, Whooley MA. Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2008; 102:1131-1135.
27. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
28. Bouzas-Mosquera A, Broullón FJ, Álvarez-García N, Peteiro J, Mosquera VX, Castro-Beiras A. Association of left ventricular mass with all-cause mortality, myocardial infarction and stroke. PLoS One 2012; 7:e45570.
29. Bang CN, Gerdts E, Aurigemma GP, Boman K, de Simone G, Dahlöf B, et al. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging 2014; 7:422-429.
30. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the Dallas heart study. Circ Cardiovasc Imaging 2010; 3 :164-171.
31. Abrignani MG, Dominguez LJ, Biondo G, Di Girolamo A, Novo G, Barbagallo M, et al. In-hospital complications of acute myocardial infarction in hypertensive subjects. Am J Hypertens 2005; 18:165-170.
32. Aursnes I, Landmark K. More non-Q-wave myocardial infarctions but similar infarct sizes in patients with hypertension. Blood Press 2000; 9:98-103.
33. Muiesan ML, Salvetti M, Paini A, Monteduro C, Galbassini G, Bonzi B, et al. Inappropriate left ventricular mass changes during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2007; 49:1077-1083.